These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28845406)

  • 1. In Vitro Hb Production in B-thalassemia Patients Is Not a Predictor of Clinical Responsiveness to Hydroxyurea.
    Mahdavi MR; Pourfarzad F; Kosaryan M; Akbari MT
    Iran J Public Health; 2017 Jul; 46(7):948-956. PubMed ID: 28845406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The XmnI and BCL11A single nucleotide polymorphisms may help predict hydroxyurea response in Iranian β-thalassemia patients.
    Banan M; Bayat H; Azarkeivan A; Mohammadparast S; Kamali K; Farashi S; Bayat N; Khani MH; Neishabury M; Najmabadi H
    Hemoglobin; 2012; 36(4):371-80. PubMed ID: 22686296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report on patients with non transfusion-dependent β-thalassemia major being treated with hydroxyurea attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013.
    Kosaryan M; Karami H; Zafari M; Yaghobi N
    Hemoglobin; 2014; 38(2):115-8. PubMed ID: 24471558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.
    Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
    Ann Hematol; 2004 Jul; 83(7):430-3. PubMed ID: 14722738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors.
    Amoyal I; Goldfarb A; Fibach E
    Hemoglobin; 2003 May; 27(2):77-87. PubMed ID: 12779269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Exon 14 of the
    Mohammadi Z; Mohammadi R; Haghpanah S; Moghadam M; Pazhoomand R; Karimi M
    Hemoglobin; 2020 Nov; 44(6):406-410. PubMed ID: 33164584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from Eastern India.
    Bohara VV; Ray S; Chakrabarti P; Ray SS; Nath UK; Chaudhuri U
    Hemoglobin; 2014; 38(1):44-8. PubMed ID: 24144212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
    Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
    Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
    Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
    Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
    Ehsani MA; Hedayati-Asl AA; Bagheri A; Zeinali S; Rashidi A
    Pediatr Hematol Oncol; 2009 Nov; 26(8):560-5. PubMed ID: 19954365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pragmatic Scoring Tool to Predict Hydroxyurea Response Among β-Thalassemia Major Patients in Pakistan.
    Ansari SH; Hussain Z; Zohaib M; Parveen S; Kaleem B; Qamar H; Adil O; Khan MT; Shamsi TS
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e77-e83. PubMed ID: 33710118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of cis-trans interplay between DNA sequences 5' to the (G)gamma- and beta-globin genes among Hb F-Malta-I heterozygotes/homozygotes and beta-thalassemia homozygotes/compound heterozygotes, and the effects of hydroxyurea on the Hb F/F-erythrocyte; the need for large multicenter trials.
    Felice AE; Borg J; Pizzuto M; Cassar W; Galdies R; Wettinger SB; Pulis S; Hunter GJ; Caruana MR; Farrugia M; Scerri CA
    Hemoglobin; 2007; 31(2):279-88. PubMed ID: 17486512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Some Single-nucleotide Polymorphism and Response to Hydroxyurea Therapy in Iranian Patients With β-Thalassemia Intermedia.
    Karimi M; Zarei T; Haghpanah S; Moghadam M; Ebrahimi A; Rezaei N; Heidari G; Vazin A; Khavari M; Miri HR
    J Pediatr Hematol Oncol; 2017 May; 39(4):e171-e176. PubMed ID: 28121747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of XmnI-HBG2, BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms on Hb F Variation of Hematologically Normal Iranian Individuals.
    Keyhani E; Jafari Vesiehsari M; Talebi Kakroodi S; Darabi E; Zamani F; Karimlou M; Kamali K; Neishabury M
    Hemoglobin; 2016 Jun; 40(3):198-201. PubMed ID: 27117569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.
    Pakdee N; Yamsri S; Fucharoen G; Sanchaisuriya K; Pissard S; Fucharoen S
    Blood Cells Mol Dis; 2014; 53(1-2):11-5. PubMed ID: 24581976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MicroRNAs Mediated in Reactivation of the γ-Globin in β-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea.
    Hojjati MT; Azarkeivan A; Pourfathollah AA; Amirizadeh N
    Hemoglobin; 2017 Mar; 41(2):110-115. PubMed ID: 28696844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic correlation between six common beta-thalassemia mutations and the XmnI polymorphism in the Moroccan population.
    Agouti I; Badens C; Abouyoub A; Khattab M; Sayah F; Barakat A; Bennani M
    Hemoglobin; 2007; 31(2):141-9. PubMed ID: 17486495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia.
    Lebensburger JD; Patel RJ; Palabindela P; Bemrich-Stolz CJ; Howard TH; Hilliard LM
    J Blood Med; 2015; 6():285-90. PubMed ID: 26719735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.